CurrentAmbetter GeorgiaPolicy CP.MP.184

Home Ventilators

Customize your policy alerts

Sign up for Ambetter Georgia Policy CP.MP.184 alerts

Get alerted when Policy CP.MP.184 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Medical necessity criteria for provision and continued use of home ventilators (noninvasive and invasive) for non‑Medicare Ambetter Georgia plans; defines indications, continuation, overlap-syndrome review, and backup/second ventilator situations.

Policy Summary

PayerAmbetter Georgia

PolicyHome Ventilators

Policy CodePolicy CP.MP.184

Change TypeNo material changes

Effective DateJun 1, 2026

Last ReviewJun 1, 2025

Next Review Date

Key ActionObtain prior authorization with documentation that the member could not be appropriately treated with a respiratory assist device (RAD) and provide objective test results per the policy criteria.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

multipleCovered indications

E0465-E0468HCPCS codes referenced

≥4 h/24hMin daily use for continuation

≥45/≥52PaCO2 thresholds

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentAmbetter GeorgiaPolicy CP.MP.184

Home Ventilators

Customize your policy alerts

Sign up for Ambetter Georgia Policy CP.MP.184 alerts

Get alerted when Policy CP.MP.184 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerAmbetter Georgia

PolicyHome Ventilators

Policy CodePolicy CP.MP.184

Change TypeNo material changes

Effective DateJun 1, 2026

Last ReviewJun 1, 2025

Next Review Date

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

multipleCovered indications

E0465-E0468HCPCS codes referenced

≥4 h/24hMin daily use for continuation

≥45/≥52PaCO2 thresholds

Initial therapy — restrictive thoracic or neuromuscular disease

Covered when ALL of the following are met for initial request (first three months):

I.A Initial restrictive thoracic/neuromuscular criteria: 1) Documentation of a neuromuscular disease (e.g., amyotrophic lateral sclerosis) or a severe thoracic cage abnormality (e.g., post‑thoracoplasty or severe kyphoscoliosis) AND one of the following measured while the member was stable (not in acute respiratory failure): (a) arterial blood gas PaCO2 ≥ 45 mm Hg measured while awake and breathing room air or on prescribed oxygen; (b) sleep oximetry demonstrating O2 saturation ≤ 88% for ≥ 5 minutes while breathing prescribed O2; (c) if neuromuscular disease present, maximal inspiratory pressure < 60 cm H2O or forced vital capacity < 50% predicted; 2) Documentation that the member could not be appropriately treated with a respiratory assist device (RAD); 3) The noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support); 4) COPD does not contribute significantly to the pulmonary limitation.see node text

Initial period specified as first three months

Initial therapy — COPD chronic respiratory failure

Covered when ALL of the following are met for initial request (first three months):

I.B Initial COPD criteria: 1) Member exhibits hypercapnia with PaCO2 ≥ 52 mm Hg by arterial blood gas obtained while awake and breathing the prescribed FiO2; 2) Sleep apnea is not the predominant cause of the hypercapnia (formal sleep testing not required if the medical record demonstrates sleep apnea is not the predominant cause); 3) At least one of the following: (a) requires oxygen therapy at FiO2 ≥ 36% or ≥ 4 L nasally; (b) requires ventilatory support > 8 hours per 24‑hour period; (c) requires a home mechanical ventilator with alarms and internal battery because the member cannot effectively breathe independently for more than a few hours and interruption would be life‑threatening; 4) Documentation that the member could not be appropriately treated with a RAD; 5) The noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).see node text

Initial period specified as first three months

Initial therapy — obesity hypoventilation syndrome (OHS)

Covered when ALL of the following are met for initial request (first three months):

I.C Initial OHS criteria: 1) BMI ≥ 30; 2) Initial arterial blood gas PaCO2 ≥ 45 mm Hg measured while awake and breathing at baseline and the prescribed FiO2; 3) Sleep‑disordered hypoventilation documented by polysomnography and other conditions are not the primary cause of hypoventilation (e.g., lung parenchymal or airway disease, chest wall disorder other than obesity mass loading, medication effects, neurologic disorder, muscle weakness, or known central alveolar hypoventilation); 4) Documentation that the member could not be appropriately treated with a RAD; 5) The noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).see node text

Initial period specified as first three months

Continuation therapy

Covered when ALL of the following are met for continued use after initial certification period:

II Continued use: A) The device is used at least an average of 4 hours per 24‑hour period; B) Documentation supports both of the following: (1) ongoing benefit from use of the device; (2) the noninvasive home ventilator is not being used to provide RAD or CPAP therapy (i.e., will be used to provide average volume‑assured pressure support).Average ≥ 4 hours per 24‑hour period

Applies after the initial three‑month certification period

Overlap syndromes

Covered when standard criteria met but requires additional step:

III Overlap syndromes: Noninvasive ventilators for overlap syndromes (presence of more than one condition, e.g., COPD plus sleep apnea) require secondary review by a medical director.N/A

Medical director secondary review required

Invasive ventilators — chronic/long-term conditions

Covered when ALL of the following are met for invasive ventilators:

IV Invasive ventilator initial/ongoing use: Initial and ongoing use is medically necessary for long‑term or chronic conditions affecting the ability to effectively maintain adequate respiratory status (examples include neuromuscular disease, thoracic restrictive disease, or chronic respiratory failure following COPD).N/A

Examples provided; clinical judgment applies

Second or backup ventilator — chronic/long-term conditions

Second or backup ventilator is considered medically necessary when ANY of the following purposes are met:

V Second or backup ventilator: A) A second ventilator serves a different purpose from the first based on medical needs (e.g., different ventilator types needed during day vs night); B) A backup ventilator is needed when either: (1) the member is confined to a wheelchair and requires a wheelchair‑mounted ventilator during the day and another ventilator for use in bed because the wheelchair ventilator cannot be positioned near the bed; (2) the member resides in a remote area with poor emergency access.N/A

Either different‑purpose device or specified backup situations

Ventilators intended primarily to provide respiratory assist device (RAD) or continuous positive airway pressure (CPAP) therapy are not eligible for approval under the noninvasive home ventilator criteria unless documentation clearly demonstrates that the device will be used to provide average volume‑assured pressure support and that RAD/CPAP therapy is inappropriate for the member.

When coverage provisions in this clinical policy conflict with state Medicaid benefit rules, the state Medicaid coverage provisions take precedence. Providers should consult the applicable state Medicaid manual for any differing coverage requirements before applying this policy.

Approval of a noninvasive home ventilator requires documentation that the member could not be appropriately managed with a respiratory assist device (RAD) or CPAP. Requests where the ventilator would be used in place of RAD/CPAP, or where RAD/CPAP would be appropriate, do not meet the noninvasive ventilator coverage criteria unless explicit documentation explains why RAD/CPAP are inappropriate and the device will be used to provide average volume‑assured pressure support.

Coding and Clinical Thresholds

Referenced HCPCS Codes for Home VentilatorsHCPCS

E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)
E0466	Home ventilator, any type, used with noninvasive interface, (e.g., mask, chest shell)
E0467	Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions
E0468	Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions

PaCO2 thresholds

PaCO2 threshold — restrictive/neuromuscularPaCO2 ≥ 45 mm Hg measured while awake and breathing room air or on prescribed oxygen

PaCO2 threshold — COPD-related chronic respiratory failurePaCO2 ≥ 52 mm Hg by arterial blood gas obtained while awake and breathing prescribed FiO2

Context for measurementPaCO2 values referenced in initial-request criteria for specific indications (restrictive/neuromuscular and COPD)

Minimum daily use for continuation

Minimum average daily use requiredDevice used at least an average of 4 hours per 24-hour period for continued coverage

Evidence needed for continuationDocumentation must support ongoing benefits from use of the device

Non-RAD/CPAP use requirementContinued coverage requires ventilator not be used to provide RAD or CPAP (used to provide average volume assured pressure support)

Oxygen requirement threshold

Oxygen requirement option (FiO2)Requires oxygen therapy at an FiO2 ≥ 36%

Oxygen requirement option (flow)Or requires ≥ 4 L nasally

Context in criteriaOne of several COPD criteria options demonstrating need for noninvasive home ventilator

BMI threshold for OHS

BMI threshold for OHSBMI ≥ 30 specified in initial OHS criteria

Associated PaCO2 requirementInitial arterial blood gas PaCO2 ≥ 45 mm Hg required in OHS criteria

Sleep testing requirementSleep-disordered hypoventilation must be documented by polysomnography unless other causes predominate

Provider Requirements and Authorization

Prior Authorization

Prior authorization required with diagnostic and objective testing

Prior authorization is required for initial and continued use of home ventilators. Requests must include documentation of the diagnosis and any objective testing required by the policy criteria (e.g., arterial blood gas PaCO2 measurements, sleep testing/oximetry, or measures of inspiratory strength/FVC).

Applies to codes E0465–E0468 referenced for home ventilators.
Required documentation examples are detailed in the policy criteria for initial and continuation requests.

Note

Clinical policy guides medical necessity and prior authorization decisions

This clinical policy is intended as a guide to medical necessity to assist coverage decisions and benefit administration; prior authorization requirements and coverage determinations are subject to the Health Plan's terms, conditions, exclusions, limitations, and administrative policies.

Does not itself guarantee payment; follow plan-level prior authorization processes and benefit documents.

Step Therapy

Document trial and inadequacy of RAD prior to ventilator approval

Approval of a noninvasive home ventilator requires documentation that the member could not be appropriately treated with a respiratory assist device (RAD) prior to ventilator approval.

Policy language: documentation that member/enrollee could not be appropriately treated with a RAD is required in initial criteria for restrictive/neuromuscular, COPD, and OHS indications.
Ventilator must not be used to provide RAD or CPAP therapy per the criteria.

Documentation Required

State intended ventilator use and include specific objective thresholds

Ensure requests explicitly state the intended ventilator use (e.g., for average volume‑assured pressure support) and that the device will not be used to provide RAD/CPAP, and include all relevant objective test results referenced in the policy.

For initial requests, include specific thresholds when present (PaCO2, BMI, FiO2/oxygen flow, hours of ventilatory support, inspiratory pressure/FVC where applicable).
Clarify whether the request is for invasive versus noninvasive ventilator and if the request is for a backup/second ventilator indicate the purpose per policy.

Documentation Required

Include diagnosis and required objective test results in documentation

Clinical documentation must include the member's diagnosis and the objective measures/tests required by the applicable policy criteria (examples: arterial blood gas PaCO2, sleep testing or oximetry, inspiratory pressure or FVC, oxygen/FiO2 requirements).

For restrictive/neuromuscular: PaCO2 ≥ 45 mm Hg or sleep oximetry ≤ 88% ≥ 5 minutes, or maximal inspiratory pressure < 60 cm H2O or FVC < 50% predicted.
For COPD: PaCO2 ≥ 52 mm Hg and documentation of FiO2 ≥ 36% or ≥ 4 L nasal oxygen if applicable, or requirement for >8 hours ventilatory support.
For OHS: BMI ≥ 30 and initial PaCO2 ≥ 45 mm Hg plus documented sleep‑disordered hypoventilation.

Note

Follow Health Plan terms and exercise professional judgment

Providers must follow the Health Plan's coverage documents, exercise professional medical judgment, and are responsible for the medical advice and treatment of members; coverage decisions remain subject to plan terms, exclusions, and limitations.

This clinical policy does not dictate clinical practice and is not a contract or guarantee of payment.
Providers remain independent contractors and must adhere to plan-level administrative policies and state/federal requirements.

Denial Risk

Missing RAD/CPAP inadequacy documentation risks denial

Requests that lack documentation showing the member could not be treated with a RAD or that the ventilator will not be used to provide RAD/CPAP are at risk for denial.

Policy exclusion: ventilators intended to provide RAD or CPAP are excluded unless documentation shows RAD/CPAP are inappropriate and device will provide average volume‑assured pressure support.

Denial Risk

Continued use must show ≥4 hours average daily use or risk denial

Continued‑use requests must document average device use of at least four hours per 24‑hour period; requests without evidence of this usage are at risk for denial.

Continuation criteria: device used at least an average of four hours per 24‑hour period and documentation of ongoing benefit.

Note

State Medicaid and NCD/LCD requirements take precedence where applicable

When state Medicaid provisions conflict with this clinical policy, the state Medicaid coverage provisions take precedence; similarly, review applicable Medicare NCDs/LCDs for consistency when treating Medicare members.

Refer to the state Medicaid manual for Medicaid members and to CMS NCDs/LCDs for Medicare members as applicable.

Home Ventilators

Sign up for Ambetter Georgia Policy CP.MP.184 alerts

Home Ventilators

Sign up for Ambetter Georgia Policy CP.MP.184 alerts

Coverage Criteria for Home Ventilators

Coding and Clinical Thresholds

Provider Requirements and Authorization

Background

Definitions